awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38624864-3A1D2C4C-3A5A-408D-B62C-DD5DA3812A07
Q38624864-3A1D2C4C-3A5A-408D-B62C-DD5DA3812A07
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38624864-3A1D2C4C-3A5A-408D-B62C-DD5DA3812A07
Optimal treatment of poor-risk renal cell carcinoma patients with mTOR inhibitors and anti-VEGFR agents.
P2860
Q38624864-3A1D2C4C-3A5A-408D-B62C-DD5DA3812A07
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38624864-3A1D2C4C-3A5A-408D-B62C-DD5DA3812A07
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ff98df58ef3ddbdbd4e2d184074f066f3de2ff26
P2860
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study.